560 related articles for article (PubMed ID: 26712783)
1. Quercetin as an Antiviral Agent Inhibits Influenza A Virus (IAV) Entry.
Wu W; Li R; Li X; He J; Jiang S; Liu S; Yang J
Viruses; 2015 Dec; 8(1):. PubMed ID: 26712783
[TBL] [Abstract][Full Text] [Related]
2. An Oleanolic Acid Derivative Inhibits Hemagglutinin-Mediated Entry of Influenza A Virus.
Ye M; Liao Y; Wu L; Qi W; Choudhry N; Liu Y; Chen W; Song G; Chen J
Viruses; 2020 Feb; 12(2):. PubMed ID: 32085430
[TBL] [Abstract][Full Text] [Related]
3. New small molecule entry inhibitors targeting hemagglutinin-mediated influenza a virus fusion.
Basu A; Antanasijevic A; Wang M; Li B; Mills DM; Ames JA; Nash PJ; Williams JD; Peet NP; Moir DT; Prichard MN; Keith KA; Barnard DL; Caffrey M; Rong L; Bowlin TL
J Virol; 2014 Feb; 88(3):1447-60. PubMed ID: 24198411
[TBL] [Abstract][Full Text] [Related]
4. Anti-influenza A Virus Activity of Dendrobine and Its Mechanism of Action.
Li R; Liu T; Liu M; Chen F; Liu S; Yang J
J Agric Food Chem; 2017 May; 65(18):3665-3674. PubMed ID: 28417634
[TBL] [Abstract][Full Text] [Related]
5. Sialic acid-mimic peptides as hemagglutinin inhibitors for anti-influenza therapy.
Matsubara T; Onishi A; Saito T; Shimada A; Inoue H; Taki T; Nagata K; Okahata Y; Sato T
J Med Chem; 2010 Jun; 53(11):4441-9. PubMed ID: 20476787
[TBL] [Abstract][Full Text] [Related]
6. Hemagglutinin Cleavability, Acid Stability, and Temperature Dependence Optimize Influenza B Virus for Replication in Human Airways.
Laporte M; Stevaert A; Raeymaekers V; Boogaerts T; Nehlmeier I; Chiu W; Benkheil M; Vanaudenaerde B; Pöhlmann S; Naesens L
J Virol; 2019 Dec; 94(1):. PubMed ID: 31597759
[TBL] [Abstract][Full Text] [Related]
7. Genetic characterization of circulating seasonal Influenza A viruses (2005-2009) revealed introduction of oseltamivir resistant H1N1 strains during 2009 in eastern India.
Agrawal AS; Sarkar M; Ghosh S; Roy T; Chakrabarti S; Lal R; Mishra AC; Chadha MS; Chawla-Sarkar M
Infect Genet Evol; 2010 Dec; 10(8):1188-98. PubMed ID: 20678590
[TBL] [Abstract][Full Text] [Related]
8. Molecular evolution of human influenza A viruses in a local area during eight influenza epidemics from 2000 to 2007.
Zaraket H; Saito R; Sato I; Suzuki Y; Li D; Dapat C; Caperig-Dapat I; Oguma T; Sasaki A; Suzuki H
Arch Virol; 2009; 154(2):285-95. PubMed ID: 19153639
[TBL] [Abstract][Full Text] [Related]
9. Antiviral Activity of the Human Cathelicidin, LL-37, and Derived Peptides on Seasonal and Pandemic Influenza A Viruses.
Tripathi S; Wang G; White M; Qi L; Taubenberger J; Hartshorn KL
PLoS One; 2015; 10(4):e0124706. PubMed ID: 25909853
[TBL] [Abstract][Full Text] [Related]
10. Identification and Characterization of Novel Compounds with Broad-Spectrum Antiviral Activity against Influenza A and B Viruses.
Park JG; Ávila-Pérez G; Nogales A; Blanco-Lobo P; de la Torre JC; Martínez-Sobrido L
J Virol; 2020 Mar; 94(7):. PubMed ID: 31941776
[TBL] [Abstract][Full Text] [Related]
11. An oligothiophene compound neutralized influenza A viruses by interfering with hemagglutinin.
Shen X; Zhu Z; Ding Y; Wu W; Yang J; Liu S
Biochim Biophys Acta Biomembr; 2018 Mar; 1860(3):784-791. PubMed ID: 29229526
[TBL] [Abstract][Full Text] [Related]
12. Role of the viral hemagglutinin in the anti-influenza virus activity of newly synthesized polycyclic amine compounds.
Torres E; Duque MD; Vanderlinden E; Ma C; Pinto LH; Camps P; Froeyen M; Vázquez S; Naesens L
Antiviral Res; 2013 Sep; 99(3):281-91. PubMed ID: 23800838
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of Periodic Treatment of Quercetin against Influenza A Virus H1N1 through Modulation of Protein Expression.
Vaidya B; Cho SY; Oh KS; Kim SH; Kim YO; Jeong EH; Nguyen TT; Kim SH; Kim IS; Kwon J; Kim D
J Agric Food Chem; 2016 Jun; 64(21):4416-25. PubMed ID: 27157719
[TBL] [Abstract][Full Text] [Related]
14. Neuraminidase inhibitor susceptibility profile of pandemic and seasonal influenza viruses during the 2009-2010 and 2010-2011 influenza seasons in Japan.
Dapat C; Kondo H; Dapat IC; Baranovich T; Suzuki Y; Shobugawa Y; Saito K; Saito R; Suzuki H
Antiviral Res; 2013 Sep; 99(3):261-9. PubMed ID: 23791870
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological evaluation of novel L-ascorbic acid-conjugated pentacyclic triterpene derivatives as potential influenza virus entry inhibitors.
Wang H; Xu R; Shi Y; Si L; Jiao P; Fan Z; Han X; Wu X; Zhou X; Yu F; Zhang Y; Zhang L; Zhang L; Zhou D; Xiao S
Eur J Med Chem; 2016 Mar; 110():376-88. PubMed ID: 26866456
[TBL] [Abstract][Full Text] [Related]
16. Super short membrane-active lipopeptides inhibiting the entry of influenza A virus.
Wu W; Wang J; Lin D; Chen L; Xie X; Shen X; Yang Q; Wu Q; Yang J; He J; Liu S
Biochim Biophys Acta; 2015 Oct; 1848(10 Pt A):2344-50. PubMed ID: 26092189
[TBL] [Abstract][Full Text] [Related]
17. Development of single-chain variable fragments (scFv) against influenza virus targeting hemagglutinin subunit 2 (HA2).
Li TW; Cheng SF; Tseng YT; Yang YC; Liu WC; Wang SC; Chou MJ; Lin YJ; Wang Y; Hsiao PW; Wu SC; Chang DK
Arch Virol; 2016 Jan; 161(1):19-31. PubMed ID: 26446888
[TBL] [Abstract][Full Text] [Related]
18. Distinct functional determinants of influenza hemagglutinin-mediated membrane fusion.
Ivanovic T; Harrison SC
Elife; 2015 Nov; 4():e11009. PubMed ID: 26613408
[TBL] [Abstract][Full Text] [Related]
19. Amantadine-resistant influenza A viruses isolated in South Korea from 2003 to 2009.
Choi WY; Kim S; Lee N; Kwon M; Yang I; Kim MJ; Cheong SG; Kwon D; Lee JY; Oh HB; Kang C
Antiviral Res; 2009 Nov; 84(2):199-202. PubMed ID: 19720085
[TBL] [Abstract][Full Text] [Related]
20. Influenza A virus entry inhibitors targeting the hemagglutinin.
Yang J; Li M; Shen X; Liu S
Viruses; 2013 Jan; 5(1):352-73. PubMed ID: 23340380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
